Agency Information Collection Activities; Proposed Collection; Comment Request; Assessing ACL's American Indian, Alaskan Natives and Native Hawaiian Programs (OMB Control Number 0985-0059), 56633-56635 [2023-17788]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 159 / Friday, August 18, 2023 / Notices
the system and concerns related to the
COVID–19 public health emergency
response. Another commenter stated the
commenter would like Medicare to
cover acupuncturists in CAHs and other
facilities.
While we appreciate the commenters’
concerns, these comments are outside of
the scope of this notice. We remain
committed to improving the quality and
safety of patients in all healthcare
settings and providing oversight of all
AOs.
V. Provisions of the Final Notice
lotter on DSK11XQN23PROD with NOTICES1
A. Differences Between TJC’s Standards
and Requirements for Accreditation and
Medicare Conditions and Survey
Requirements
We compared TJC’s CAH
requirements and survey process with
the Medicare CoPs and survey process
as outlined in the State Operations
Manual (SOM). Our review and
evaluation of TJC’s CAH application
were conducted as described in section
III of this notice and yielded the
following areas where, as of the date of
this notice, TJC’s has completed revising
its standards and certification processes
in order to:
• Meet the standard’s requirements
for all of the following regulations:
++ Section 485.604(a)(2), to clarify the
requirements for education including a
master’s or doctoral level degree in a
defined clinical area of nursing from an
accredited educational institution.
++ Section 485.616(c)(4)(iv), to specify
the requirement of an internal review of
the distant-site physician’s or
practitioner’s performance of the
privileges at the CAH whose patients are
receiving the telemedicine services.
++ Section 485.623(b)(1), to specify
that all essential mechanical, electrical
and patient care equipment is
maintained in safe operating condition.
++ Section 485.635(b)(3), to include
reference to State law within the
standard for radiology services.
In addition to the standards review,
CMS also reviewed TJC’s comparable
survey processes, which were
conducted as described in section III of
this notice, and yielded the following
areas where, as of the date of this notice,
TJC has completed revising its survey
processes, in order to demonstrate that
it uses survey processes that are
comparable to state survey agency
processes by:
• Revising TJC’s surveyor guide to
ensure a comprehensive review of
environmental safety and life safety
requirements are performed.
• Revising TJC’s surveyor guide and
survey processes to ensure compliance
VerDate Sep<11>2014
18:26 Aug 17, 2023
Jkt 259001
with the Medicare-conditions are
assessed at each provider-based location
where care is provided per CAH
Appendix W of the SOM.
• Providing training and education to
surveyors related to the use of openended questions during staff interviews
to elicit information, consistent with
chapter 2, section 2714 of the SOM.
• Revising the survey instructions
and providing education to surveyors to
conduct patient interviews. In
accordance with CAH Appendix WTask 3—Information Gathering/
Investigation of the SOM, surveyors
must observe the actual provision of
care and services to patients and
conduct patient interviews throughout
the course of the survey.
• Review and assess TJC’s surveyor
time and resource allocations of the
number of surveyors on site consistent
with § 488.5(a)(5), § 488.5(a)(6) and
§ 488.5(a)(9) to ensure sufficient time is
allotted to conduct all required survey
activities.
• Provide additional training and
education to surveyors on procedures
related to investigation of ‘‘immediate
jeopardy’’ situations in accordance with
appendix Q-section VI of the SOM.
• Review and revise TJC’s complaint
investigation process, specifically to
ensure the complainant (when not
anonymous), receives an
acknowledgement letter and closure
letter, as outlined within chapter 5,
sections 5010.2 and 5080.1 of the SOM.
• Review TJC’s elements of
performance and survey deficiency
findings to ensure any deficiencies are
appropriately correlated or matched
with a Medicare condition, when
appropriate, in accordance with
§ 488.5(a)(4)(ii).
B. Term of Approval
Based on our review and observations
described in section III and section V of
this notice, we approve TJC as a
national AO for CAHs that request
participation in the Medicare program.
The decision announced in this final
notice is effective November 21, 2023
through November 21, 2027 (4 years).
VI. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
56633
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Vanessa Garcia who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Vanessa Garcia,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2023–17745 Filed 8–17–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Assessing ACL’s
American Indian, Alaskan Natives and
Native Hawaiian Programs (OMB
Control Number 0985–0059)
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is providing
an opportunity for the public to
comment on the proposed collection of
information listed above. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish a notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
a proposed extension without change
information collection and solicits
comments on the information collection
requirements related to the project titled
Assessing ACL’s American Indian,
Alaskan Natives and Native Hawaiian
Programs (OMB Control Number 0985–
0059).
DATES: Comments on the collection of
information must be submitted
electronically by 11:59 p.m. (EST) or
postmarked by October 17, 2023.
ADDRESSES: Submit electronic
comments on the collection of
information to: Administration for
Community Living at evaluation@
acl.hhs.gov. Submit written comments
on the collection of information to the
Administration for Community Living,
Washington, DC 20201, Attention:
Administration for Community Living.
FOR FURTHER INFORMATION CONTACT: The
Office of Performance and Evaluation,
Administration for Community Living
evaluation@acl.hhs.gov.
SUMMARY:
E:\FR\FM\18AUN1.SGM
18AUN1
56634
Federal Register / Vol. 88, No. 159 / Friday, August 18, 2023 / Notices
Under the
Paperwork Reduction Act, Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor. A
collection of information includes
agency requests or requirements that
members of the public submit reports,
keep records, or provide information to
a third party. The PRA requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, ACL is publishing a notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, ACL invites
comments on our burden estimates or
any other aspect of this collection of
information, including:
(1) whether the proposed collection of
information is necessary for the proper
performance of ACL’s functions,
including whether the information will
have practical utility;
(2) the accuracy of ACL’s estimate of
the burden of the proposed collection of
information, including the validity of
the methodology and assumptions used
to determine burden estimates;
(3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) ways to minimize the burden of
the collection of information on
respondents, including using automated
collection techniques when appropriate,
and other forms of information
technology.
The Administration for Community
Living (ACL) is requesting approval for
data collection associated with the
project entitled Assessing ACL’s
American Indian, Alaska Natives, and
Native Hawaiian Programs (Older
Americans Act [OAA] Title VI; short
title: Assessment of the Title VI
Programs). OAA Title VI establishes
grants to Native Americans for nutrition
services, supportive services, and family
caregiver support services. The purpose
of Title VI is ‘‘to promote the delivery
of supportive services, including
nutrition services, to American Indians,
Alaskan Natives, and Native Hawaiians
that are comparable to services provided
under Title III’’ (42 U.S.C. 3057), which
provides nutrition, caregiver and
supportive services to the broader U.S.
population. Title VI is comprised of
three parts; Part A provides nutrition
and supportive services to American
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:26 Aug 17, 2023
Jkt 259001
Indians and Alaska Natives, Part B
provides nutrition and supportive
services to Native Hawaiians, and Part
C provides caregiver services to any
programs that have Part A/B.
The previous data collection for this
project entailed a series of interviews
and focus groups with Title VI program
staff, elders, and caregivers.
American Indian, Alaska Native, and
Native Hawaiian (AI/AN/NH)
populations experience significant
health and socioeconomic disparities
compared to the rest of the U.S.
population. The AI/AN population has
the highest rate of disabilities and the
lowest life expectancy compared to the
averages for the overall population
(Centers for Disease Control and
Prevention [CDC], 2008; Goins, Moss,
Buchwald, & Guralnik, 2007). While
18% of the non-Hispanic white
population is 65 years or older, just 8%
of Native Hawaiians and 10% of the AI/
AN population is 65 years or older
(AoA, 2015). However, as overall life
expectancy increases, the proportion of
older AI/AN adults is expected to
increase. By 2050, the percentage of
non-Hispanic white adults is expected
to decrease by 20%, while the
population of older minority population
adults, including AI/AN/NH, is
expected to increase by 110% (AoA,
2015; CDC, 2013). For AI/AN
populations, this translates to a 93%
increase in the number of older adults.
In addition, the population aged 75
and older needing long-term care is
expected to double by the year 2030
(AoA, 2015; CDC 2013; Goins et al.,
2007).
In fiscal year 2023, ACL awarded 291
Title VI three-year grants to tribes/tribal
organizations elders for the provision of
nutrition and supportive services, and a
portion of awardees also received funds
for the Native American Caregiver
Support Program. The Assessment of
the Title VI Programs will examine the
effects of the program on:
1. Older Indians, their families and
caregivers
2. Tribal communities
3. Intergenerational connections in
tribal communities
4. Management of the Title VI program
The Need for Continuous Assessment
Assessing and evaluating Title VI
Programs is authorized under Section
206(a, c) of Title II of the OAA, which
directs ACL to ‘‘. . . measure and
evaluate the impact of all programs
authorized by this Act, their
effectiveness in achieving stated goals in
general, and in relation to their cost,
their impact on related programs, their
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
effectiveness in targeting for services
under this Act unserved older
individuals with greatest economic need
(including low-income minority
individuals and older individuals
residing in rural areas) and unserved
older individuals with greatest social
need (including low-income minority
individuals and older individuals
residing in rural areas), and their
structure and mechanisms for delivery
of services, including, where
appropriate, comparisons with
appropriate control groups composed of
persons who have not participated in
such programs.’’
Consistent with requirements of the
Government Performance Results
Modernization Act (GPRMA), ACL’s
Administration on Aging (AoA)
integrates its strategic priorities and
plans with performance measurement
criteria. The AoA has three categories of
performance measures: improve
program efficiency, improve client
outcomes, and improve effective
targeting of vulnerable elders. Through
continuous assessment, ACL seeks a
better understanding of key programs,
such as the programs under Title VI of
the OAA for AI/AN/NH.
This project seeks to add a qualitative
data collection activity to do follow-up
interviews with grantees a to
understand which components of the
technical assistance they have received
have been the most useful for them.
Exhibit 1 provides an overview of the
process for assessing the Title VI
Program data collection activity.
Exhibit 1
The Program Staff Follow-up
Interviews will assess how the Title VI
Programs have been utilizing and
implementing the Technical Assistance
they have received from the contractor
around the practice of evaluation. Data
will include how evaluation practice is
being implemented and on what
occurring basis, as well as perceptions
of met and unmet needs around
evaluation; and barriers to using
evaluation. Up to 2 local staff (e.g.,
program director and evaluation staff
person) will participate in each
interview. The interviews will be
conducted via telephone in Year 4 with
up to 12 evaluation grantees, for a
maximum of 24 participants, and will
take 60 minutes to complete. See
Attachment A (Title VI Program Staff
Consent Form and Interview Guide).
The proposed data collection tools
may be found on the ACL website for
review at https://www.acl.gov/aboutacl/public-input.
E:\FR\FM\18AUN1.SGM
18AUN1
56635
Federal Register / Vol. 88, No. 159 / Friday, August 18, 2023 / Notices
ESTIMATED PROGRAM BURDEN
Respondent type
Form name
Program director ...............................
Program staff follow-up interview
guide.
Dated: August 14, 2023.
Alison Barkoff,
Senior official performing the duties of the
Administrator and the Assistant Secretary for
Aging.
[FR Doc. 2023–17788 Filed 8–17–23; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–P–1549]
Determination That BORTEZOMIB
(Bortezomib) Solution, 2.5 Milligrams/
Milliliter and 3.5 Milligrams/1.4 Milliliter
(2.5 Milligrams/Milliliter), Was Not
Withdrawn From Sale for Reasons of
Safety or Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we)
has determined that BORTEZOMIB
(bortezomib) solution, 2.5 milligrams
(mg)/milliliter (mL) and 3.5 mg/1.4 mL
(2.5 mg/mL), was not withdrawn from
sale for reasons of safety or
effectiveness. This determination will
allow FDA to approve abbreviated new
drug applications (ANDAs) for
BORTEZOMIB (bortezomib) solution,
2.5 mg/mL and 3.5 mg/1.4 mL (2.5 mg/
mL), if all other legal and regulatory
requirements are met.
FOR FURTHER INFORMATION CONTACT:
Donna Tran, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 6213, Silver Spring,
MD 20993–0002, 301–796–3600,
Donna.Tran@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Section
505(j) of the Federal Food, Drug, and
Cosmetic Act (FD&C Act) (21 U.S.C.
355(j)) allows the submission of an
ANDA to market a generic version of a
previously approved drug product. To
obtain approval, the ANDA applicant
must show, among other things, that the
generic drug product: (1) has the same
active ingredient(s), dosage form, route
of administration, strength, conditions
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:26 Aug 17, 2023
Jkt 259001
Number of
annual
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Annual
burden hours
80
1
1
80
of use, and (with certain exceptions)
labeling as the listed drug, which is a
version of the drug that was previously
approved, and (2) is bioequivalent to the
listed drug. ANDA applicants do not
have to repeat the extensive clinical
testing otherwise necessary to gain
approval of a new drug application
(NDA).
Section 505(j)(7) of the FD&C Act
requires FDA to publish a list of all
approved drugs. FDA publishes this list
as part of the ‘‘Approved Drug Products
With Therapeutic Equivalence
Evaluations,’’ which is known generally
as the ‘‘Orange Book.’’ Under FDA
regulations, drugs are removed from the
list if the Agency withdraws or
suspends approval of the drug’s NDA or
ANDA for reasons of safety or
effectiveness or if FDA determines that
the listed drug was withdrawn from sale
for reasons of safety or effectiveness (21
CFR 314.162).
A person may petition the Agency to
determine, or the Agency may
determine on its own initiative, whether
a listed drug was withdrawn from sale
for reasons of safety or effectiveness.
This determination may be made at any
time after the drug has been withdrawn
from sale but must be made prior to
approving an ANDA that refers to the
listed drug (§ 314.161 (21 CFR 314.161)).
FDA may not approve an ANDA that
does not refer to a listed drug.
BORTEZOMIB (bortezomib) solution,
2.5 mg/mL and 3.5 mg/1.4 mL (2.5 mg/
mL), is the subject of NDA 215441, held
by Accord Healthcare Inc., and initially
approved on July 26, 2022.
BORTEZOMIB is indicated for the
treatment of adult patients with
multiple myeloma or mantle cell
lymphoma.
In a letter dated February 8, 2023,
Accord Healthcare Inc. notified FDA
that BORTEZOMIB (bortezomib)
solution, 2.5 mg/mL and 3.5 mg/1.4 mL
(2.5 mg/mL), was being discontinued,
and FDA moved the drug product to the
‘‘Discontinued Drug Product List’’
section of the Orange Book.
Qilu Pharmaceutical (Hainan) Co.,
Ltd. submitted a citizen petition dated
April 19, 2023 (Docket No. FDA–2023–
P–1549), under 21 CFR 10.30,
requesting that the Agency determine
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
whether BORTEZOMIB (bortezomib)
solution, 2.5 mg/mL and 3.5 mg/1.4 mL
(2.5 mg/mL), was withdrawn from sale
for reasons of safety or effectiveness.
After considering the citizen petition
and reviewing Agency records and
based on the information we have at this
time, FDA has determined under
§ 314.161 that BORTEZOMIB
(bortezomib) solution, 2.5 mg/mL and
3.5 mg/1.4 mL (2.5 mg/mL), was not
withdrawn for reasons of safety or
effectiveness. The petitioner has
identified no data or other information
suggesting that BORTEZOMIB
(bortezomib) solution, 2.5 mg/mL and
3.5 mg/1.4 mL (2.5 mg/mL), was
withdrawn for reasons of safety or
effectiveness. We have carefully
reviewed our files for records
concerning the withdrawal of
BORTEZOMIB (bortezomib) solution,
2.5 mg/mL and 3.5 mg/1.4 mL (2.5 mg/
mL), from sale. We have also
independently evaluated relevant
literature and data for possible
postmarketing adverse events. We have
found no information that would
indicate that this drug product was
withdrawn from sale for reasons of
safety or effectiveness.
Accordingly, the Agency will
continue to list BORTEZOMIB
(bortezomib) solution, 2.5 mg/mL and
3.5 mg/1.4 mL (2.5 mg/mL), in the
‘‘Discontinued Drug Product List’’
section of the Orange Book. The
‘‘Discontinued Drug Product List’’
delineates, among other items, drug
products that have been discontinued
from marketing for reasons other than
safety or effectiveness. ANDAs that refer
to these drug products may be approved
by the Agency as long as they meet all
other legal and regulatory requirements
for the approval of ANDAs. If FDA
determines that labeling for these drug
products should be revised to meet
current standards, the Agency will
advise ANDA applicants to submit such
labeling.
Dated: August 14, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–17746 Filed 8–17–23; 8:45 am]
BILLING CODE 4164–01–P
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 88, Number 159 (Friday, August 18, 2023)]
[Notices]
[Pages 56633-56635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Agency Information Collection Activities; Proposed Collection;
Comment Request; Assessing ACL's American Indian, Alaskan Natives and
Native Hawaiian Programs (OMB Control Number 0985-0059)
AGENCY: Administration for Community Living, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration for Community Living (ACL) is providing an
opportunity for the public to comment on the proposed collection of
information listed above. Under the Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to publish a notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on a proposed extension without change
information collection and solicits comments on the information
collection requirements related to the project titled Assessing ACL's
American Indian, Alaskan Natives and Native Hawaiian Programs (OMB
Control Number 0985-0059).
DATES: Comments on the collection of information must be submitted
electronically by 11:59 p.m. (EST) or postmarked by October 17, 2023.
ADDRESSES: Submit electronic comments on the collection of information
to: Administration for Community Living at [email protected].
Submit written comments on the collection of information to the
Administration for Community Living, Washington, DC 20201, Attention:
Administration for Community Living.
FOR FURTHER INFORMATION CONTACT: The Office of Performance and
Evaluation, Administration for Community Living [email protected].
[[Page 56634]]
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act, Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor. A
collection of information includes agency requests or requirements that
members of the public submit reports, keep records, or provide
information to a third party. The PRA requires Federal agencies to
provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
of an existing collection of information, before submitting the
collection to OMB for approval. To comply with this requirement, ACL is
publishing a notice of the proposed collection of information set forth
in this document.
With respect to the following collection of information, ACL
invites comments on our burden estimates or any other aspect of this
collection of information, including:
(1) whether the proposed collection of information is necessary for
the proper performance of ACL's functions, including whether the
information will have practical utility;
(2) the accuracy of ACL's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used to determine burden estimates;
(3) ways to enhance the quality, utility, and clarity of the
information to be collected; and
(4) ways to minimize the burden of the collection of information on
respondents, including using automated collection techniques when
appropriate, and other forms of information technology.
The Administration for Community Living (ACL) is requesting
approval for data collection associated with the project entitled
Assessing ACL's American Indian, Alaska Natives, and Native Hawaiian
Programs (Older Americans Act [OAA] Title VI; short title: Assessment
of the Title VI Programs). OAA Title VI establishes grants to Native
Americans for nutrition services, supportive services, and family
caregiver support services. The purpose of Title VI is ``to promote the
delivery of supportive services, including nutrition services, to
American Indians, Alaskan Natives, and Native Hawaiians that are
comparable to services provided under Title III'' (42 U.S.C. 3057),
which provides nutrition, caregiver and supportive services to the
broader U.S. population. Title VI is comprised of three parts; Part A
provides nutrition and supportive services to American Indians and
Alaska Natives, Part B provides nutrition and supportive services to
Native Hawaiians, and Part C provides caregiver services to any
programs that have Part A/B.
The previous data collection for this project entailed a series of
interviews and focus groups with Title VI program staff, elders, and
caregivers.
American Indian, Alaska Native, and Native Hawaiian (AI/AN/NH)
populations experience significant health and socioeconomic disparities
compared to the rest of the U.S. population. The AI/AN population has
the highest rate of disabilities and the lowest life expectancy
compared to the averages for the overall population (Centers for
Disease Control and Prevention [CDC], 2008; Goins, Moss, Buchwald, &
Guralnik, 2007). While 18% of the non-Hispanic white population is 65
years or older, just 8% of Native Hawaiians and 10% of the AI/AN
population is 65 years or older (AoA, 2015). However, as overall life
expectancy increases, the proportion of older AI/AN adults is expected
to increase. By 2050, the percentage of non-Hispanic white adults is
expected to decrease by 20%, while the population of older minority
population adults, including AI/AN/NH, is expected to increase by 110%
(AoA, 2015; CDC, 2013). For AI/AN populations, this translates to a 93%
increase in the number of older adults.
In addition, the population aged 75 and older needing long-term
care is expected to double by the year 2030 (AoA, 2015; CDC 2013; Goins
et al., 2007).
In fiscal year 2023, ACL awarded 291 Title VI three-year grants to
tribes/tribal organizations elders for the provision of nutrition and
supportive services, and a portion of awardees also received funds for
the Native American Caregiver Support Program. The Assessment of the
Title VI Programs will examine the effects of the program on:
1. Older Indians, their families and caregivers
2. Tribal communities
3. Intergenerational connections in tribal communities
4. Management of the Title VI program
The Need for Continuous Assessment
Assessing and evaluating Title VI Programs is authorized under
Section 206(a, c) of Title II of the OAA, which directs ACL to ``. . .
measure and evaluate the impact of all programs authorized by this Act,
their effectiveness in achieving stated goals in general, and in
relation to their cost, their impact on related programs, their
effectiveness in targeting for services under this Act unserved older
individuals with greatest economic need (including low-income minority
individuals and older individuals residing in rural areas) and unserved
older individuals with greatest social need (including low-income
minority individuals and older individuals residing in rural areas),
and their structure and mechanisms for delivery of services, including,
where appropriate, comparisons with appropriate control groups composed
of persons who have not participated in such programs.''
Consistent with requirements of the Government Performance Results
Modernization Act (GPRMA), ACL's Administration on Aging (AoA)
integrates its strategic priorities and plans with performance
measurement criteria. The AoA has three categories of performance
measures: improve program efficiency, improve client outcomes, and
improve effective targeting of vulnerable elders. Through continuous
assessment, ACL seeks a better understanding of key programs, such as
the programs under Title VI of the OAA for AI/AN/NH.
This project seeks to add a qualitative data collection activity to
do follow-up interviews with grantees a to understand which components
of the technical assistance they have received have been the most
useful for them.
Exhibit 1 provides an overview of the process for assessing the
Title VI Program data collection activity.
Exhibit 1
The Program Staff Follow-up Interviews will assess how the Title VI
Programs have been utilizing and implementing the Technical Assistance
they have received from the contractor around the practice of
evaluation. Data will include how evaluation practice is being
implemented and on what occurring basis, as well as perceptions of met
and unmet needs around evaluation; and barriers to using evaluation. Up
to 2 local staff (e.g., program director and evaluation staff person)
will participate in each interview. The interviews will be conducted
via telephone in Year 4 with up to 12 evaluation grantees, for a
maximum of 24 participants, and will take 60 minutes to complete. See
Attachment A (Title VI Program Staff Consent Form and Interview Guide).
The proposed data collection tools may be found on the ACL website
for review at https://www.acl.gov/about-acl/public-input.
[[Page 56635]]
Estimated Program Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Number of Average burden
Respondent type Form name annual responses per per response Annual burden
respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Program director................................ Program staff follow-up interview 80 1 1 80
guide.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: August 14, 2023.
Alison Barkoff,
Senior official performing the duties of the Administrator and the
Assistant Secretary for Aging.
[FR Doc. 2023-17788 Filed 8-17-23; 8:45 am]
BILLING CODE 4154-01-P
